| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $496.3M | +23.2% |
| Cost of Revenue | $235.0M | +15.2% |
| Gross Profit | $261.3M | +31.4% |
| R&D Expense | $13.1M | +48.9% |
| SG&A Expense | $143.6M | +28.0% |
| Operating Income | $106.2M | +21.2% |
| Interest Expense | $25.7M | -50.8% |
| Pre-tax Income | $80.6M | +177.3% |
| Income Tax | $8.4M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $84.8M | +56.9% |
| Accounts Receivable | $88.0M | +37.9% |
| Inventory | $109.0M | +17.7% |
| Current Assets | $298.5M | +35.3% |
| Total Assets | $2.03B | +39.9% |
| Current Liabilities | $63.5M | +51.9% |
| Long-term Debt | $715.7M | +158.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $112.3M | +104.3% |
| Investing Cash Flow | -$520.9M | -32.8% |
| Financing Cash Flow | $439.2M | +18.7% |
| +23.5% |
| Net Income | $72.1M | +224.5% |
| EPS (Basic) | $0.77 | +208.0% |
| EPS (Diluted) | $0.75 | +212.5% |
| Total Liabilities |
| $855.1M |
| +136.1% |
| Stockholders' Equity | $1.17B | +7.9% |